Retinal toxicity screening underused for hydroxychloroquine therapy│ EULAR

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway 

  • There were significant deficiencies in guideline-based screening in Irish patients treated with hydroxychloroquine (HCQ) for connective tissue disease, with a high level of toxicity shown in patients who did undergo screening.   

Why this matters 

  • HCQ-related visual toxicity is u...